| abstract |
Provided herein are biomarkers associated with lung cancer. Saliva biomarkers identified in the present invention (CCNI, EGFR, FGF9, GREB1 protein, LZTS, BRAF, FRS2, ANXA1, haptoglobin Hp2, zinc alpha2-glycoprotein, calprotectin, porphyromonas catonia, 16S rRNA , 16S rRNA, Streptococcus salivarius 16S rRNA, Campylobacter rex 16S rRNA, Bayonella parbula 16S rRNA, Kinggella Oralis 16S rRNA, and Granulica teria denses 16S rRNA) And a basis for bioassay for detecting lung cancer with specificity. Means and methods of evaluating data generated using a plurality of biomarkers to substantiate findings, as well as additional uses of multiplexed lung cancer assays in clinical, diagnostic, and therapeutic uses. |